- Home
- AMLX vs ABL Comparison
AMLX vs ABL Comparison
Compare AMLX & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- ABL
- Stock Information
- Founded
- AMLX 2014
- ABL 2004
- Country
- AMLX United States
- ABL United States
- Employees
- AMLX N/A
- ABL N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- AMLX Health Care
- ABL Finance
- Exchange
- AMLX Nasdaq
- ABL Nasdaq
- Market Cap
- AMLX 749.9M
- ABL 602.4M
- IPO Year
- AMLX 2022
- ABL N/A
- Fundamental
- Price
- AMLX $8.00
- ABL $6.41
- Analyst Decision
- AMLX Strong Buy
- ABL Strong Buy
- Analyst Count
- AMLX 7
- ABL 3
- Target Price
- AMLX $12.00
- ABL $12.83
- AVG Volume (30 Days)
- AMLX 1.0M
- ABL 619.5K
- Earning Date
- AMLX 08-07-2025
- ABL 08-07-2025
- Dividend Yield
- AMLX N/A
- ABL N/A
- EPS Growth
- AMLX N/A
- ABL N/A
- EPS
- AMLX N/A
- ABL N/A
- Revenue
- AMLX N/A
- ABL $161,724,466.00
- Revenue This Year
- AMLX N/A
- ABL $69.03
- Revenue Next Year
- AMLX N/A
- ABL $26.72
- P/E Ratio
- AMLX N/A
- ABL N/A
- Revenue Growth
- AMLX N/A
- ABL 69.56
- 52 Week Low
- AMLX $2.05
- ABL $4.60
- 52 Week High
- AMLX $8.72
- ABL $11.00
- Technical
- Relative Strength Index (RSI)
- AMLX 53.91
- ABL 68.40
- Support Level
- AMLX $7.48
- ABL $5.43
- Resistance Level
- AMLX $8.49
- ABL $6.43
- Average True Range (ATR)
- AMLX 0.40
- ABL 0.30
- MACD
- AMLX -0.06
- ABL 0.14
- Stochastic Oscillator
- AMLX 51.49
- ABL 98.44
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.